Literature DB >> 20074063

Regulation of cyclin D1 gene expression.

Ini-Isabée Witzel1, Li Fang Koh, Neil D Perkins.   

Abstract

Cyclin D1 is a key regulator of cell proliferation and its expression is subject to both transcriptional and post-transcriptional regulation. In different cellular contexts, different pathways assume a dominant role in regulating its expression, whereas their disregulation can contribute to overexpression of cyclin D1 in tumorigenesis. Here, we discuss the ability of the NF-kappaB (nuclear factor kappaB)/IKK [IkappaB (inhibitor of NF-kappaB) kinase] pathways to regulate cyclin D1 gene transcription and also consider the newly discovered role of the SNARP (SNIP1/SkIP-associated RNA processing) complex as a co-transcriptional regulator of cyclin D1 RNA stability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074063     DOI: 10.1042/BST0380217

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  56 in total

1.  Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Authors:  Shaun Rosebeck; Lisa Madden; Xiaohong Jin; Shufang Gu; Ingrid J Apel; Alex Appert; Rifat A Hamoudi; Heidi Noels; Xavier Sagaert; Peter Van Loo; Mathijs Baens; Ming-Qing Du; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Science       Date:  2011-01-28       Impact factor: 47.728

2.  Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.

Authors:  Swapnil Parashram Bhavsar; Cecilie Løkke; Trond Flægstad; Christer Einvik
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

3.  Clinical significance and biological roles of TRIM24 in human bladder carcinoma.

Authors:  Dongwei Xue; Xiuwei Zhang; Xilin Zhang; Jia Liu; Ning Li; Chunlai Liu; Yili Liu; Ping Wang
Journal:  Tumour Biol       Date:  2015-04-07

4.  MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.

Authors:  Zhen Liang; Shiqi Li; Xin Xu; Xianglai Xu; Xiao Wang; Jian Wu; Yi Zhu; Zhenghui Hu; Yiwei Lin; Yeqing Mao; Hong Chen; Jindan Luo; Ben Liu; Xiangyi Zheng; Liping Xie
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

5.  CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.

Authors:  Shiyu Du; Liping Jia; Yanli Zhang; Long Fang; Xiang Zhang; Yanhua Fan
Journal:  Tumour Biol       Date:  2014-03-16

6.  t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.

Authors:  Junyang Li; Hongyi Liu; Biao Xing; Yanzhe Yu; Hui Wang; Gong Chen; Bing Gu; Guofeng Zhang; Dong Wei; Peiyuan Gu; Meng Li; Weixing Hu
Journal:  J Neurooncol       Date:  2012-03-02       Impact factor: 4.130

7.  Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.

Authors:  Jun Guo; Lixiang Yang; Jianfeng Huang; Xiancheng Liu; Xiaojun Qiu; Tao Tao; Yonghua Liu; Xiaojuan He; Na Ban; Shaochen Fan; Guan Sun
Journal:  Med Oncol       Date:  2014-07-02       Impact factor: 3.064

8.  Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Zhangyong Hu; Zhipeng Zhou; Guolian Xiong; Yali Wang; Yi Lai; Lan Deng; Jinliang Yang
Journal:  Tumour Biol       Date:  2014-02-26

9.  Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.

Authors:  A R Garcia-Rendueles; J S Rodrigues; M E R Garcia-Rendueles; M Suarez-Fariña; S Perez-Romero; F Barreiro; I Bernabeu; J Rodriguez-Garcia; L Fugazzola; T Sakai; F Liu; J Cameselle-Teijeiro; S B Bravo; C V Alvarez
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

10.  Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.

Authors:  Jingjie Zhang; Weiming Ouyang; Jingxia Li; Dongyun Zhang; Yonghui Yu; York Wang; Xuejun Li; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.